An Australian-made version of a pain drug once banned in the US because of toxicity concerns is to be relaunched overseas after approval by European health regulators.
Medical Developments International has invested $10 million developing its inhalable drug and is looking forward to sales soaring, with the market for emergency pain relief in Britain and Europe worth up to $200m a year.
Hey, check out all the engineering jobs. Post your resume today!
